SEO URLwww.firestrike.ai/deals/insilico-medicine-qilu-pharmaceutical-acquisition-2026
acquisitionAnnounced · Jan 28, 2026PharmaceuticalsSource · CredibleArticle · Factual
Qilu Pharmaceutical acquires Insilico Medicine
David Najork · Founding Software Engineer
Announced · Updated · 1 min read
Deal value
$120M
Target
Insilico Medicine
Cambridge, Massachusetts
Acquirer
Qilu Pharmaceutical
Strategic Partnership
Status
Announced
Qilu Pharmaceutical agreed to acquire Insilico Medicine. Reported deal value: $120M. Status: Announced. Sector: Pharmaceuticals. Target headquarters context: Cambridge, Massachusetts, United States.
This page summarizes publicly available information about the transaction as of 2026-01-28. Figures and status may change as filings and press coverage update.
EXEL Insilico Medicine has entered a strategic partnership with Qilu Pharmaceutical and its subsidiary Shanghai Qilu Pharmaceutical Research Center on drug development for cardiometabolic diseases
Deal timeline
Announced
Jan 28, 2026 · finance.yahoo.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in Pharmaceuticals with a reported deal value of $120M. Figures and status may change as sources update.
Sources: finance.yahoo.com · Primary article · FireStrike proprietary index